Stock Analysis on Net

Align Technology Inc. (NASDAQ:ALGN)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Common Stock Valuation Ratios (Price Multiples)

Microsoft Excel

Current Valuation Ratios

Align Technology Inc., current price multiples

Microsoft Excel
Align Technology Inc. Abbott Laboratories Elevance Health Inc. Intuitive Surgical Inc. Medtronic PLC UnitedHealth Group Inc. Health Care Equipment & Services Health Care
Selected Financial Data
Current share price (P) $197.44
No. shares of common stock outstanding 76,589,114
Growth rate (g) 34.50%
 
Earnings per share (EPS) $4.72
Next year expected EPS $6.35
Operating profit per share $8.39
Sales per share $48.76
Book value per share (BVPS) $47.02
Valuation Ratios (Price Multiples)
Price to earnings (P/E) 41.82 27.82 16.40 52.78 25.24 29.89 22.99 30.60
Price to next year expected earnings 31.09 25.80 14.67 46.28 24.90 26.62 20.62 26.77
Price-earnings-growth (PEG) 1.21 3.55 1.39 3.76 18.42 2.44 2.00 2.14
Price to operating profit (P/OP) 23.53 22.54 14.13 51.18 18.74 19.00 17.50 23.91
Price to sales (P/S) 4.05 4.09 0.47 14.98 3.33 0.81 1.62 4.48
Price to book value (P/BV) 4.20 3.48 2.12 8.46 2.45 3.83 4.23 7.59

Based on: 10-K (reporting date: 2022-12-31).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.


Historical Valuation Ratios (Summary)

Align Technology Inc., historical price multiples

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Price to earnings (P/E) 64.55 52.31 25.27 38.84 51.76
Price to operating profit (P/OP) 36.32 41.36 115.91 31.70 44.40
Price to sales (P/S) 6.25 10.22 18.15 7.14 10.53
Price to book value (P/BV) 6.48 11.15 13.88 12.77 16.53

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).


The valuation multiples for Align Technology Inc. exhibit significant volatility between 2018 and 2022, characterized by a distinct divergence in trends between earnings-based and asset-based metrics. A notable period of instability is observed around 2020, where several ratios peaked sharply before adjusting in subsequent years.

Price to Earnings (P/E) Ratio
The P/E ratio followed a U-shaped trajectory. A steady contraction occurred from 2018 to 2020, with the ratio falling from 51.76 to a period low of 25.27. This was followed by a rapid expansion, climbing to 52.31 in 2021 and reaching a peak of 64.55 by the end of 2022, suggesting a significant increase in the premium investors were willing to pay per unit of earnings.
Price to Operating Profit (P/OP) Ratio
This metric displayed the highest degree of volatility. After a moderate decline between 2018 and 2019, the ratio surged to an anomalous peak of 115.91 in 2020. Following this spike, the ratio corrected sharply, returning to a range of 36.32 to 41.36 during 2021 and 2022, indicating a temporary and severe misalignment between market price and operating profitability in 2020.
Price to Sales (P/S) Ratio
The P/S ratio peaked in 2020 at 18.15, marking a sharp increase from 7.14 in 2019. However, a consistent downward trend followed, with the ratio retreating to 10.22 in 2021 and further declining to 6.25 by 2022. This represents the lowest valuation relative to revenue observed within the analyzed five-year period.
Price to Book Value (P/BV) Ratio
A general downward trend is observed in the P/BV ratio over the long term. From a high of 16.53 in 2018, the ratio decreased to 6.48 by 2022. While a slight increase occurred in 2020, the overall trajectory indicates a compression in the market's valuation of the company relative to its equity book value.

In summary, while earnings-based multiples expanded toward the end of the period, sales and book value multiples contracted. The extreme fluctuations observed in 2020 across the P/OP and P/S ratios suggest a period of significant market volatility or fundamental shifts in operational efficiency that were later normalized.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Price to Earnings (P/E)

Align Technology Inc., historical P/E calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
No. shares of common stock outstanding1 76,610,319 78,795,494 79,132,723 78,753,161 79,989,347
Selected Financial Data (US$)
Net income (in thousands) 361,573 772,020 1,775,888 442,776 400,235
Earnings per share (EPS)2 4.72 9.80 22.44 5.62 5.00
Share price1, 3 304.64 512.56 567.11 218.35 258.97
Valuation Ratio
P/E ratio4 64.55 52.31 25.27 38.84 51.76
Benchmarks
P/E Ratio, Competitors5
Abbott Laboratories 26.76 29.13 — — —
Elevance Health Inc. 19.20 18.13 — — —
Intuitive Surgical Inc. 64.99 59.94 — — —
Medtronic PLC 23.38 46.56 — — —
UnitedHealth Group Inc. 22.46 26.03 — — —
P/E Ratio, Sector
Health Care Equipment & Services 24.26 28.98 — — —
P/E Ratio, Industry
Health Care 21.22 21.55 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Data adjusted for splits and stock dividends.

2 2022 Calculation
EPS = Net income ÷ No. shares of common stock outstanding
= 361,573,000 ÷ 76,610,319 = 4.72

3 Closing price as at the filing date of Align Technology Inc. Annual Report.

4 2022 Calculation
P/E ratio = Share price ÷ EPS
= 304.64 ÷ 4.72 = 64.55

5 Click competitor name to see calculations.


An analysis of the valuation metrics from 2018 through 2022 reveals a period of significant volatility in both market pricing and fundamental earnings, resulting in a fluctuating price-to-earnings (P/E) profile.

Earnings and Share Price Correlation
A substantial peak in financial performance occurred in 2020, where earnings per share (EPS) rose sharply to 22.44 US$, coinciding with a peak share price of 567.11 US$. Following this peak, a consistent downward trajectory in EPS is observed, falling to 9.80 US$ in 2021 and further declining to 4.72 US$ by the end of 2022. The share price followed a similar downward trend after 2020, ending the period at 304.64 US$.
P/E Ratio Dynamics
The P/E ratio exhibited an inverse relationship with earnings growth during the center of the observed period. Despite the surge in share price in 2020, the exceptional growth in EPS led to a valuation contraction, with the P/E ratio dropping to its lowest point of 25.27. Conversely, from 2021 to 2022, the P/E ratio expanded significantly, rising from 52.31 to a period high of 64.55.
Valuation Expansion Trend
By the end of 2022, a valuation expansion is evident. While the share price in 2022 remained higher than the 2018 level, the EPS fell below the 2018 baseline of 5.00 US$. This divergence resulted in the highest P/E ratio of the five-year sequence, indicating that the market assigned a higher multiple to the company's earnings in 2022 than in any previous year analyzed.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Price to Operating Profit (P/OP)

Align Technology Inc., historical P/OP calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
No. shares of common stock outstanding1 76,610,319 78,795,494 79,132,723 78,753,161 79,989,347
Selected Financial Data (US$)
Income from operations (in thousands) 642,595 976,400 387,171 542,493 466,564
Operating profit per share2 8.39 12.39 4.89 6.89 5.83
Share price1, 3 304.64 512.56 567.11 218.35 258.97
Valuation Ratio
P/OP ratio4 36.32 41.36 115.91 31.70 44.40
Benchmarks
P/OP Ratio, Competitors5
Abbott Laboratories 22.18 24.45 — — —
Elevance Health Inc. 15.05 15.70 — — —
Intuitive Surgical Inc. 54.49 56.11 — — —
Medtronic PLC 20.48 37.44 — — —
UnitedHealth Group Inc. 15.89 18.77 — — —
P/OP Ratio, Sector
Health Care Equipment & Services 18.47 22.66 — — —
P/OP Ratio, Industry
Health Care 16.58 18.20 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Data adjusted for splits and stock dividends.

2 2022 Calculation
Operating profit per share = Income from operations ÷ No. shares of common stock outstanding
= 642,595,000 ÷ 76,610,319 = 8.39

3 Closing price as at the filing date of Align Technology Inc. Annual Report.

4 2022 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= 304.64 ÷ 8.39 = 36.32

5 Click competitor name to see calculations.


The valuation profile from 2018 to 2022 exhibits significant volatility, characterized by a dramatic divergence between market price and operational earnings in 2020, followed by a period of correction and stabilization.

Share Price Fluctuations
The share price experienced a substantial increase between 2019 and 2020, rising from 218.35 to a peak of 567.11. This was followed by a steady decline over the subsequent two years, closing at 304.64 by the end of 2022.
Operating Profit per Share Trends
Operational profitability showed inconsistent growth. After an initial increase in 2019, profit per share declined to 4.89 in 2020. A significant recovery occurred in 2021, where profit per share reached a peak of 12.39, before moderating to 8.39 in 2022.
Price to Operating Profit (P/OP) Dynamics
The P/OP ratio remained relatively stable between 31.70 and 44.40 for most of the period, with the exception of a severe spike to 115.91 in 2020. This outlier was driven by the simultaneous occurrence of a peak in share price and a trough in operating profit per share. By 2022, the ratio normalized to 36.32, suggesting that the market valuation returned to a level more closely aligned with historical operational performance.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Price to Sales (P/S)

Align Technology Inc., historical P/S calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
No. shares of common stock outstanding1 76,610,319 78,795,494 79,132,723 78,753,161 79,989,347
Selected Financial Data (US$)
Net revenues (in thousands) 3,734,635 3,952,584 2,471,941 2,406,796 1,966,492
Sales per share2 48.75 50.16 31.24 30.56 24.58
Share price1, 3 304.64 512.56 567.11 218.35 258.97
Valuation Ratio
P/S ratio4 6.25 10.22 18.15 7.14 10.53
Benchmarks
P/S Ratio, Competitors5
Abbott Laboratories 4.25 4.78 — — —
Elevance Health Inc. 0.74 0.81 — — —
Intuitive Surgical Inc. 13.81 17.89 — — —
Medtronic PLC 3.72 5.57 — — —
UnitedHealth Group Inc. 1.40 1.58 — — —
P/S Ratio, Sector
Health Care Equipment & Services 1.71 2.07 — — —
P/S Ratio, Industry
Health Care 3.11 3.28 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Data adjusted for splits and stock dividends.

2 2022 Calculation
Sales per share = Net revenues ÷ No. shares of common stock outstanding
= 3,734,635,000 ÷ 76,610,319 = 48.75

3 Closing price as at the filing date of Align Technology Inc. Annual Report.

4 2022 Calculation
P/S ratio = Share price ÷ Sales per share
= 304.64 ÷ 48.75 = 6.25

5 Click competitor name to see calculations.


An analysis of the valuation metrics from 2018 to 2022 reveals a period of significant volatility in market pricing contrasted with a consistent upward trajectory in revenue per share.

Price to Sales (P/S) Ratio Volatility
The P/S ratio experienced substantial fluctuations, peaking at 18.15 in 2020 before contracting to a five-year low of 6.25 by the end of 2022. This movement indicates a significant shift in market sentiment and the valuation premiums attributed to the revenue stream.
Revenue Performance Trends
Sales per share demonstrated sustained growth over the analyzed period, rising from US$ 24.58 in 2018 to US$ 48.75 in 2022. The most pronounced acceleration occurred between 2020 and 2021, during which sales per share increased from US$ 31.24 to US$ 50.16.
Valuation Divergence and Compression
A sharp divergence is observed in 2020, where the share price surged to US$ 567.11, driving the P/S ratio to its peak despite only marginal growth in sales per share for that year. In contrast, 2022 marked a period of valuation compression; the share price declined to US$ 304.64 while sales per share remained relatively stable at US$ 48.75, leading to a significant reduction in the price multiple.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?


Price to Book Value (P/BV)

Align Technology Inc., historical P/BV calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
No. shares of common stock outstanding1 76,610,319 78,795,494 79,132,723 78,753,161 79,989,347
Selected Financial Data (US$)
Stockholders’ equity (in thousands) 3,601,358 3,622,714 3,233,865 1,346,169 1,252,891
Book value per share (BVPS)2 47.01 45.98 40.87 17.09 15.66
Share price1, 3 304.64 512.56 567.11 218.35 258.97
Valuation Ratio
P/BV ratio4 6.48 11.15 13.88 12.77 16.53
Benchmarks
P/BV Ratio, Competitors5
Abbott Laboratories 5.06 5.75 — — —
Elevance Health Inc. 3.19 3.07 — — —
Intuitive Surgical Inc. 7.78 8.59 — — —
Medtronic PLC 2.24 3.26 — — —
UnitedHealth Group Inc. 5.81 6.27 — — —
P/BV Ratio, Sector
Health Care Equipment & Services 4.46 5.01 — — —
P/BV Ratio, Industry
Health Care 5.26 5.48 — — —

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Data adjusted for splits and stock dividends.

2 2022 Calculation
BVPS = Stockholders’ equity ÷ No. shares of common stock outstanding
= 3,601,358,000 ÷ 76,610,319 = 47.01

3 Closing price as at the filing date of Align Technology Inc. Annual Report.

4 2022 Calculation
P/BV ratio = Share price ÷ BVPS
= 304.64 ÷ 47.01 = 6.48

5 Click competitor name to see calculations.


An analysis of the price-to-book value (P/BV) trajectory from 2018 to 2022 reveals a general compression of the valuation multiple, occurring alongside a consistent increase in the underlying book value per share.

Book Value Per Share (BVPS) Growth
A steady upward trend in book value per share is observed, with values increasing from 15.66 US$ in 2018 to 47.01 US$ in 2022. A significant acceleration in equity accumulation occurred between 2019 and 2020, where BVPS rose from 17.09 US$ to 40.87 US$, representing a substantial expansion of the company's net asset value.
Share Price Volatility
The share price demonstrated significant volatility throughout the period. After a moderate decline in 2019, the price peaked at 567.11 US$ in 2020. This was followed by a corrective trend, with the price descending to 512.56 US$ in 2021 and further decreasing to 304.64 US$ by the end of 2022.
P/BV Ratio Interpretation
The P/BV ratio transitioned from a high of 16.53 in 2018 to a low of 6.48 in 2022. Although the surge in share price in 2020 temporarily maintained the ratio at 13.88 despite the doubling of book value, the subsequent decline in market price combined with continued BVPS growth led to a sharp contraction in the multiple. This indicates that the market is paying a significantly lower premium over the book value in 2022 compared to the start of the analyzed period.

The overall trend indicates a shift toward a more conservative valuation multiple, as the growth in the company's accounting equity has outpaced the growth in its market capitalization over the long term.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?